Enhanced vertical alveolar bone augmentation by recombinant human bone morphogenetic protein-2 with a carrier in rats

C. Shimazu, Tetsuya Hara, Y. Kinuta, K. Moriya, Yukinori Maruo, S. Hanada, Shougo Minagi

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

This study aimed to evaluate the effect of recombinant human bone morphogenetic protein-2 (rhBMP-2) on vertical bone regeneration of edentulous ridge. Bilateral upper first and second molars of 8-week-old Wistar rats were extracted and the ridges were allowed to heal for 3 weeks. Compressed poly(lactic-co-glycolic acid) copolymer/gelatin sponge (PGS) was used as a carrier of rhBMP-2. PGS alone (control group) or PGS with 5 μg rhBMP-2 (test group) was implanted at the top part of alveolar ridge. The sham group received no implantation. The rats were killed at 1, 2, 4, 8 and 12 weeks after implantation and examined histologically and histomorphometrically. In the test group, significant bone augmentation was evident on the alveolar ridge throughout the experimental period. Histomorphometric analysis revealed greater tissue volume and height of alveolar bone in the test group compared with the control and sham groups (P <0.05) from 4 weeks onward and the augmented tissues (5 mm3 in tissue volume and 1.5 mm in bone height) were maintained until 12 weeks. Osteoblast surface increased at 2 and 4 weeks and osteoid thickness reached a peak (25 μm) at 2 weeks. Dynamic variables, which represented calcification, were higher in the test group than the control and sham groups at 4 and 8 weeks (P <0.05). These results suggest that use of rhBMP-2/PGS may achieve vertical bone augmentation, and stabilizes denture prosthesis or makes up for inadequate bone mass for implant prosthesis.

Original languageEnglish
Pages (from-to)609-618
Number of pages10
JournalJournal of Oral Rehabilitation
Volume33
Issue number8
DOIs
Publication statusPublished - Aug 2006

Fingerprint

Bone and Bones
Alveolar Process
Control Groups
Prostheses and Implants
Bone Regeneration
Dentures
Porifera
Gelatin
Osteoblasts
Wistar Rats
recombinant human bone morphogenetic protein-2

Keywords

  • Bone morphogenetic proteins
  • Bone regeneration
  • Edentulous ridge
  • Polylactic acid polyglycolic acid copolymer/gelatin sponge
  • Vertical bone augmentation

ASJC Scopus subject areas

  • Dentistry(all)

Cite this

Enhanced vertical alveolar bone augmentation by recombinant human bone morphogenetic protein-2 with a carrier in rats. / Shimazu, C.; Hara, Tetsuya; Kinuta, Y.; Moriya, K.; Maruo, Yukinori; Hanada, S.; Minagi, Shougo.

In: Journal of Oral Rehabilitation, Vol. 33, No. 8, 08.2006, p. 609-618.

Research output: Contribution to journalArticle

@article{def5a93ccbab465eb531851d8dc03bee,
title = "Enhanced vertical alveolar bone augmentation by recombinant human bone morphogenetic protein-2 with a carrier in rats",
abstract = "This study aimed to evaluate the effect of recombinant human bone morphogenetic protein-2 (rhBMP-2) on vertical bone regeneration of edentulous ridge. Bilateral upper first and second molars of 8-week-old Wistar rats were extracted and the ridges were allowed to heal for 3 weeks. Compressed poly(lactic-co-glycolic acid) copolymer/gelatin sponge (PGS) was used as a carrier of rhBMP-2. PGS alone (control group) or PGS with 5 μg rhBMP-2 (test group) was implanted at the top part of alveolar ridge. The sham group received no implantation. The rats were killed at 1, 2, 4, 8 and 12 weeks after implantation and examined histologically and histomorphometrically. In the test group, significant bone augmentation was evident on the alveolar ridge throughout the experimental period. Histomorphometric analysis revealed greater tissue volume and height of alveolar bone in the test group compared with the control and sham groups (P <0.05) from 4 weeks onward and the augmented tissues (5 mm3 in tissue volume and 1.5 mm in bone height) were maintained until 12 weeks. Osteoblast surface increased at 2 and 4 weeks and osteoid thickness reached a peak (25 μm) at 2 weeks. Dynamic variables, which represented calcification, were higher in the test group than the control and sham groups at 4 and 8 weeks (P <0.05). These results suggest that use of rhBMP-2/PGS may achieve vertical bone augmentation, and stabilizes denture prosthesis or makes up for inadequate bone mass for implant prosthesis.",
keywords = "Bone morphogenetic proteins, Bone regeneration, Edentulous ridge, Polylactic acid polyglycolic acid copolymer/gelatin sponge, Vertical bone augmentation",
author = "C. Shimazu and Tetsuya Hara and Y. Kinuta and K. Moriya and Yukinori Maruo and S. Hanada and Shougo Minagi",
year = "2006",
month = "8",
doi = "10.1111/j.1365-2842.2005.01593.x",
language = "English",
volume = "33",
pages = "609--618",
journal = "Journal of Oral Rehabilitation",
issn = "0305-182X",
publisher = "Wiley-Blackwell",
number = "8",

}

TY - JOUR

T1 - Enhanced vertical alveolar bone augmentation by recombinant human bone morphogenetic protein-2 with a carrier in rats

AU - Shimazu, C.

AU - Hara, Tetsuya

AU - Kinuta, Y.

AU - Moriya, K.

AU - Maruo, Yukinori

AU - Hanada, S.

AU - Minagi, Shougo

PY - 2006/8

Y1 - 2006/8

N2 - This study aimed to evaluate the effect of recombinant human bone morphogenetic protein-2 (rhBMP-2) on vertical bone regeneration of edentulous ridge. Bilateral upper first and second molars of 8-week-old Wistar rats were extracted and the ridges were allowed to heal for 3 weeks. Compressed poly(lactic-co-glycolic acid) copolymer/gelatin sponge (PGS) was used as a carrier of rhBMP-2. PGS alone (control group) or PGS with 5 μg rhBMP-2 (test group) was implanted at the top part of alveolar ridge. The sham group received no implantation. The rats were killed at 1, 2, 4, 8 and 12 weeks after implantation and examined histologically and histomorphometrically. In the test group, significant bone augmentation was evident on the alveolar ridge throughout the experimental period. Histomorphometric analysis revealed greater tissue volume and height of alveolar bone in the test group compared with the control and sham groups (P <0.05) from 4 weeks onward and the augmented tissues (5 mm3 in tissue volume and 1.5 mm in bone height) were maintained until 12 weeks. Osteoblast surface increased at 2 and 4 weeks and osteoid thickness reached a peak (25 μm) at 2 weeks. Dynamic variables, which represented calcification, were higher in the test group than the control and sham groups at 4 and 8 weeks (P <0.05). These results suggest that use of rhBMP-2/PGS may achieve vertical bone augmentation, and stabilizes denture prosthesis or makes up for inadequate bone mass for implant prosthesis.

AB - This study aimed to evaluate the effect of recombinant human bone morphogenetic protein-2 (rhBMP-2) on vertical bone regeneration of edentulous ridge. Bilateral upper first and second molars of 8-week-old Wistar rats were extracted and the ridges were allowed to heal for 3 weeks. Compressed poly(lactic-co-glycolic acid) copolymer/gelatin sponge (PGS) was used as a carrier of rhBMP-2. PGS alone (control group) or PGS with 5 μg rhBMP-2 (test group) was implanted at the top part of alveolar ridge. The sham group received no implantation. The rats were killed at 1, 2, 4, 8 and 12 weeks after implantation and examined histologically and histomorphometrically. In the test group, significant bone augmentation was evident on the alveolar ridge throughout the experimental period. Histomorphometric analysis revealed greater tissue volume and height of alveolar bone in the test group compared with the control and sham groups (P <0.05) from 4 weeks onward and the augmented tissues (5 mm3 in tissue volume and 1.5 mm in bone height) were maintained until 12 weeks. Osteoblast surface increased at 2 and 4 weeks and osteoid thickness reached a peak (25 μm) at 2 weeks. Dynamic variables, which represented calcification, were higher in the test group than the control and sham groups at 4 and 8 weeks (P <0.05). These results suggest that use of rhBMP-2/PGS may achieve vertical bone augmentation, and stabilizes denture prosthesis or makes up for inadequate bone mass for implant prosthesis.

KW - Bone morphogenetic proteins

KW - Bone regeneration

KW - Edentulous ridge

KW - Polylactic acid polyglycolic acid copolymer/gelatin sponge

KW - Vertical bone augmentation

UR - http://www.scopus.com/inward/record.url?scp=33745699643&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33745699643&partnerID=8YFLogxK

U2 - 10.1111/j.1365-2842.2005.01593.x

DO - 10.1111/j.1365-2842.2005.01593.x

M3 - Article

C2 - 16856959

AN - SCOPUS:33745699643

VL - 33

SP - 609

EP - 618

JO - Journal of Oral Rehabilitation

JF - Journal of Oral Rehabilitation

SN - 0305-182X

IS - 8

ER -